Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Mutations where in vitro MIC determination has demonstrated significantly elevated MICs of moxifloxacin
Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli.
Mutation in the quinolone resistance-determining region (QRDR) of parC
Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India.
Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.
Analysis of Neisseria gonorrhoeae and Mycoplasma genitalium from nucleic acid amplification test specimens, Nunavut region of Inuit Nunangat, Canada, 2020-2023.
Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
A Comprehensive Account of Escherichia coli Sequence Type 131 in Wastewater Reveals an Abundance of Fluoroquinolone-Resistant Clade A Strains.
Mutations in parC were identified in clade A strains, contributing to fluoroquinolone resistance.
An investigation of the presence and antimicrobial susceptibility of Enterobacteriaceae in raw and cooked kibble diets for dogs in the United Kingdom.
Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.
Rapid Detection of Antimicrobial Resistance in Mycoplasma genitalium by High-Resolution Melting Analysis with Unlabeled Probes.
Mutations in the parC gene are responsible for fluoroquinolone resistance in Mycoplasma genitalium.
Evolution of ciprofloxacin resistance in Salmonella Typhimurium and its impact on virulence and colonization
Mutations identified in the quinolone resistance-determining regions
In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.
Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin; CARD accession: CARD:3004630
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research